Neuroone Medical Technologies Income Statement (2010-2026) | NMTC

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Income Statement	Jun2021	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025	Dec2025	Mar2026
Revenue & cost
Revenue (Quarter)	0.04M	0.05M	0.03M	0.04M	0.03M	0.07M	0.11M	0.47M	0.63M	0.74M	0.98M	1.38M	0.83M	0.27M	3.27M	1.39M	1.70M	2.74M	2.89M	2.39M
Cost of Revenue (Quarter)	0.06M	0.07M	0.05M	0.07M	0.04M	0.08M	0.13M	0.43M	0.39M	0.55M	0.71M	0.99M	0.54M	0.13M	0.20M	0.20M	0.78M	1.21M	0.17M	0.22M
Gross Profit (Quarter)	-0.02M	-0.02M	-0.01M	-0.04M	-0.01M	-0.02M	-0.01M	0.03M	0.24M	0.19M	0.27M	0.39M	0.28M	0.14M	1.93M	0.77M	0.91M	1.53M	1.57M	1.29M
Operating items
Research & Development (Quarter)	0.90M	1.01M	1.06M	1.21M	1.23M	1.44M	1.56M	1.71M	1.89M	1.78M	1.48M	1.27M	1.19M	1.11M	1.00M	1.34M	1.18M	1.12M	1.39M	1.47M
Selling, General & Administrative (Quarter)	2.13M	1.62M	1.74M	1.82M	1.53M	1.89M	1.66M	1.82M	1.86M	1.58M	2.17M	2.00M	1.88M	0.44M	2.04M	1.94M	1.62M	1.78M	1.89M	1.50M
Other Operating Expenses (Quarter)														1.40M	0.17M	0.17M				0.42M
Operating Expenses (Quarter)	3.03M	2.63M	2.80M	3.02M	2.76M	3.33M	3.23M	3.53M	3.75M	3.36M	3.66M	3.28M	3.08M	2.96M	3.22M	3.45M	2.80M	2.90M	3.28M	3.39M
Operating Income (Quarter)	-3.03M	-2.64M	-2.81M	-3.06M	-2.76M	-1.40M	-1.78M	-3.50M	-3.51M	-3.16M	-3.39M	-2.89M	-2.79M	-2.82M	1.71M	-2.68M	-1.89M	-1.37M	-1.71M	-2.10M
EBIT (Quarter)	-3.03M	-2.64M	-2.81M	-3.06M	-2.76M	-1.40M	-1.78M	-3.50M	-3.51M	-3.16M	-3.39M	-2.89M	-2.79M	-2.82M	1.71M	-2.68M	-1.89M	-1.37M	-1.71M	-2.10M
Non-operating items
Other Non Operating Income (Quarter)							0.05M	-0.03M	0.04M	0.03M	0.05M	0.03M	0.03M	0.02M	0.01M	0.02M	0.08M	0.07M	0.05M	0.02M
Non Operating Income (Quarter)	0.08M							-0.03M	0.04M	0.03M	0.05M	0.03M	0.03M	0.02M	0.01M	0.02M
Net income details
EBT (Quarter)	-2.95M	-2.64M	-2.81M	-3.06M	-2.76M	-1.37M	-1.73M	-3.52M	-3.47M	-3.14M	-3.34M	-2.86M	-2.77M	-3.35M	1.79M	-2.27M	-1.50M	-1.62M	-1.44M	-2.09M
Profit After Tax (Quarter)	-2.95M	-2.64M	-2.81M	-3.06M	-2.76M	-1.37M	-1.73M	-3.52M	-3.47M	-3.14M	-3.34M	-2.86M	-2.77M	-3.35M	1.79M	-2.27M	-1.50M	-1.62M	-1.44M	-2.09M
Income from Continuing Operations (Quarter)	-2.95M	-2.64M	-2.81M	-3.06M	-2.76M	-1.37M	-1.73M	-3.52M	-3.47M	-3.14M	-3.34M	-2.86M	-2.77M	-3.35M	1.79M	-2.27M	-1.50M	-1.62M	-1.44M	-2.09M
Consolidated Net Income (Quarter)	-2.95M	-2.64M	-2.81M	-3.06M	-2.76M	-1.37M	-1.73M	-3.52M	-3.47M	-3.14M	-3.34M	-2.86M	-2.77M	-3.35M	1.79M	-2.27M	-1.50M	-1.62M	-1.44M	-2.09M
Income towards Parent Company (Quarter)	-2.95M	-2.64M	-2.81M	-3.06M	-2.76M	-1.37M	-1.73M	-3.52M	-3.47M	-3.14M	-3.34M	-2.86M	-2.77M	-3.35M	1.79M	-2.27M	-1.50M	-1.62M	-1.44M	-2.09M
Net Income towards Common Stockholders (Quarter)	-2.95M	-2.64M	-2.81M	-3.06M	-2.76M	-1.37M	-1.73M	-3.52M	-3.47M	-3.14M	-3.34M	-2.86M	-2.77M	-3.35M	1.79M	-2.27M	-1.50M	-1.62M	-1.44M	-2.09M
Additional items
EPS (Basic) (Quarter)	-0.25	-0.22	-0.18	-0.19	-0.17	-0.09	-0.11	-0.21	-0.20	-0.13	-0.14	-0.11	-0.10	-0.11	0.06	-0.44	-0.03	-0.04	-0.03	-0.25
EPS (Weighted Average and Diluted) (Quarter)	-0.25	-0.25	-0.18	-0.19	-0.17	-0.09	-0.11	-0.22	-0.20	-0.17	-0.14	-0.11	-0.10	-0.11	0.06	-0.44	-0.03	-0.04	-0.03	-0.25
Shares Outstanding (Weighted Average) (Quarter)	10.27M	10.70M	15.41M	16.19M	15.93M	16.00M	16.23M	16.32M	16.74M	18.12M	24.00M	24.95M	27.35M	26.76M	30.84M	5.16M	36.85M	0.10M	50.33M	8.48M
Shares Outstanding (Diluted Average) (Quarter)	11.96M	10.70M	15.41M	15.79M	15.93M	16.00M	16.23M	16.32M	17.58M	18.12M	24.00M	24.95M	27.35M	26.76M	30.88M	5.16M	48.60M	40.15M	50.33M	8.48M
EBITDA (Quarter)	-3.03M	-2.64M	-2.81M	-3.06M	-2.76M	-1.40M	-1.78M	-3.50M	-3.51M	-3.16M	-3.39M	-2.89M	-2.79M	-2.82M	1.71M	-2.68M	-1.89M	-1.37M	-1.71M	-2.10M
Interest Expenses (Quarter)

Research Tools

Neuroone Medical Technologies Income Statement (2010-2026) | NMTC

Create an account

Sign In

Reset Password